For providers

The Numbers That Point to an Asthma Component

November 5, 2026

Editorial illustration for the article "The Numbers That Point to an Asthma Component"

A clinical brief for referring providers — week 2 of a 4-part series on asthma-COPD overlap.

A question before the clinical note: Which CT finding is most characteristic of the asthma component in asthma-COPD overlap, and is associated with increased mortality?

a) Extensive centrilobular emphysema b) Honeycombing and traction bronchiectasis c) Airway wall thickening with mucus plugging d) Mosaic attenuation only e) Pleural plaques

Most working definitions of ACO start in the same place: persistent airflow limitation — post-BD FEV1/FVC below 0.70 — in a patient aged 40 or older with significant smoking or noxious exposure. Then they ask for features of asthma.

Common major criteria (Leung & Sin, Chest 2022)

Strong bronchodilator reversibility, or bronchial hyperreactivity

A physician diagnosis of asthma, often childhood-onset

A smoking history of at least 10 pack-years

Features that support the asthma component

FeNO — Above 35–50 ppb

Blood eosinophils — Above 300/μL, or above 5%

Reversibility — ΔFEV1 above 12% and above 200 mL

History — Variable or paroxysmal symptoms; asthma before age 40

Atopy — Perennial allergic rhinitis; elevated total or specific IgE

Biomarkers overlap. Bronchodilator responsiveness and blood eosinophils alone do not reliably separate asthma, COPD and ACO — though eosinophils and FeNO tend to run higher in ACO (GOLD 2026).

When it stays uncertain

A 58-year-old man with 20 pack-years, dyspnea and intermittent wheeze. FEV1/FVC 0.66, a modest bronchodilator response of 8% and 150 mL, eosinophils 180/μL, FeNO 22 ppb, and no clear childhood asthma. The biomarkers are intermediate and the history is absent.

Use the syndromic approach and treat for safety: if any asthma feature emerges, include ICS. Then reassess over time. Repeat spirometry and reversibility, pre-OCS eosinophils, the FeNO trend, and a CT for the airway-versus-emphysema pattern all sharpen the picture.

Rule out the mimics

Bronchiectasis, heart failure, interstitial lung disease, lung cancer and TB can all present this way, and older patients converge from both directions: long-standing asthma with airway remodeling resembles COPD, and some COPD shows reversibility.

Book a 20-minute clinical briefing

ACO is one of the least evidence-based areas in airways disease. Twenty minutes with the Chest & Sleep Team, lunch provided, on how we sort it.

Call (847) 860-7250.

Sources: GINA 2026; GOLD 2026; Leung & Sin, Chest 2022; Mekov et al., Int J COPD 2021.

Abbreviations: ACO, asthma-COPD overlap. BD, bronchodilator. FEV1/FVC, air forced out in the first second divided by the total. FeNO, fractional exhaled nitric oxide. IgE, immunoglobulin E. ICS, inhaled corticosteroid. OCS, oral corticosteroid. Pack-year, packs per day multiplied by years smoked.

The answer

Airway wall thickening with mucus plugging. ACO tends to show greater airway wall thickness and less emphysema than COPD alone; mucus plugging is more common, and its extent is associated with increased mortality (GOLD 2026).